Skip to main content

Table 4 The 5-year and 8-year overall survival rates, event free survival rates, cumulated incidence of relapse and 2-year therapy-related mortality for each groups

From: Reduced intensity of early intensification does not increase the risk of relapse in children with standard risk acute lymphoblastic leukemia - a multi-centric clinical study of GD-2008-ALL protocol

 

SR groups

IR groups

HR groups

p

5-year OS (%)

90.7±1.4

86.0±1.2

68.5±2.5

< 0.01

8-year OS (%)

89.6±1.6

85.8±1.3

68.5±2.5

< 0.01

5-year EFS (%)

83.1±1.8

77.6±1.5

61.6±2.6

< 0.01

8-year EFS (%)

81.6±2.0

76.3±1.6

61.6±2.6

< 0.01

5-year CIR (%)

15.1±1.8

19.1±1.5

26.7±2.5

< 0.01

8-year CIR (%)

16.4±1.9

20.1±1.5

26.7±2.5

< 0.01

2-yearTRM (%)

1.7±0.6

3.9±0.7

12.7±1.8

< 0.01

  1. Abbreviations: OS overall survival, EFS event free survival, CIR cumulated incidence of relapse, TRM therapy related mortality, SR standard risk, IR intermediate risk, HR high risk
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us